last
year
recombin
dna
revolut
catalyz
discoveri
fundament
principl
biolog
continu
lead
translat
applic
human
medicin
agricultur
new
era
start
small
group
scientist
recogn
potenti
recombin
dna
technolog
work
humankind
met
asilomar
discuss
way
forward
selfimpos
moratorium
recombin
dna
research
gave
way
experiment
follow
principl
asilomar
confer
code
practic
formul
nation
bodi
variou
countri
signific
input
scientist
result
develop
transpar
bestpractic
system
scienc
assur
potenti
recombin
dna
research
could
achiev
safe
manner
remain
model
regul
scienc
scientist
unit
state
first
iter
recombin
dna
research
guidelin
nation
institut
health
nih
guidelin
draft
public
input
nation
institut
health
feder
advisori
committe
eventu
becam
known
recombin
dna
advisori
committe
rac
see
also
chapter
initi
rac
review
princip
investig
pi
initi
propos
refer
registr
document
involv
recombin
dna
sinc
review
approv
registr
document
condit
deleg
institut
biosafeti
committe
ibc
research
establish
see
also
chapter
draft
nih
guidelin
static
modifi
new
technolog
develop
understand
risk
evolv
intuit
empir
base
new
knowledg
led
cdc
nih
initi
nih
guidelin
start
point
partnership
life
scienc
commun
develop
code
practic
biosafeti
microbiolog
biomed
laboratori
collabor
result
public
biosafeti
microbiolog
biomed
laboratori
bmbl
last
year
best
practic
base
nih
guidelin
bmbl
help
ensur
safeti
laboratori
worker
public
rise
nonstatesponsor
terror
latter
part
last
centuri
recognit
biotechnolog
pervas
life
scienc
research
dualus
natur
requir
new
approach
identifi
evalu
research
risk
respons
threat
govern
enact
antiterror
effect
death
penalti
act
usa
patriot
act
bioterror
prepared
respons
act
see
also
chapter
togeth
legisl
made
illeg
possess
biolog
agent
toxin
nonpeac
purpos
regard
danger
pathogen
toxin
known
biolog
select
agent
toxin
bsat
act
mandat
registr
crimin
background
check
user
regulatori
system
storag
transport
creation
class
restrict
person
prohibit
access
see
also
chapter
implement
legisl
could
unintend
consequ
make
unit
state
vulner
bioterror
slow
block
develop
diagnost
prophylact
therapeut
need
protect
countri
bioterror
nation
research
council
nation
academi
scienc
form
committe
research
standard
practic
prevent
destruct
applic
biotechnolog
charg
committe
prevent
destruct
applic
biotechnolog
research
recommend
chang
practic
could
improv
us
capac
prevent
destruct
applic
biotechnolog
research
still
enabl
legitim
research
conduct
ref
committe
focus
biotechnolog
research
potenti
caus
catastroph
harm
misus
bsat
well
research
could
creation
novel
pathogen
uniqu
properti
creat
entir
new
class
threat
agent
ref
committe
publish
report
entitl
biotechnolog
research
age
terror
nrc
report
provid
seven
recommend
tabl
togeth
design
intend
minim
impedi
fundament
research
identifi
research
greatest
potenti
misus
addit
scrutini
nrc
report
recommend
concern
dualus
research
dur
danger
pathogen
toxin
would
implement
selfgovern
scientif
commun
exist
regulatori
practic
seven
recommend
recommend
pertin
ibc
recommend
arguabl
one
import
propos
comprehens
educ
person
involv
life
scienc
research
bsat
regard
dualus
dilemma
remain
three
recommend
focus
actual
system
regul
dur
bsat
recommend
suggest
ibc
alreadi
review
experi
involv
recombin
synthet
dna
infecti
agent
would
also
review
dur
bsat
belong
seven
categori
see
recommend
propos
creation
nation
scienc
advisori
board
biosecur
nsabb
nsabb
propos
provid
casespecif
oversight
research
commun
dissemin
relev
nation
secur
biodefens
see
also
chapter
addit
would
act
advisori
capac
alert
govern
novel
find
nation
secur
implic
furthermor
nsabb
would
serv
resourc
provid
educ
outreach
advic
journal
concern
dur
eg
influenza
gainoffunct
controversi
intern
engag
scientist
profession
organ
furthermor
nsabb
would
conduct
period
review
implement
current
legisl
exist
regul
ensur
optim
balanc
maintain
stimul
lifesci
research
ensur
nation
secur
recommend
final
nrc
report
recogn
key
role
feder
fund
would
play
develop
new
system
implement
system
requir
signific
addit
resourc
stage
attempt
provid
estim
cost
otherwis
concern
unfund
mandat
could
signific
barrier
full
consider
propos
scientif
commun
ref
recommend
intern
policymak
scientif
commun
creat
intern
forum
biosecur
develop
promot
harmon
nation
region
intern
measur
provid
counterpart
system
recommend
unit
state
addit
propos
detail
process
evalu
dur
institut
level
institut
review
entiti
ire
report
emphas
import
mandatori
educ
train
life
scientist
feder
fund
institut
code
conduct
scientist
laboratori
personnel
work
life
scienc
align
field
public
involv
dur
debat
importantli
nsabb
report
reiter
concern
nrc
report
oversight
dur
becom
anoth
unfund
mandat
eleven
year
nrc
report
year
nsabb
report
us
govern
usg
fulli
implement
robust
system
evalu
dur
particular
usg
fail
effect
fund
support
expand
role
local
institut
biosafeti
committe
oversight
dur
chang
scientif
landscap
comprehens
educ
program
life
scienc
research
regard
dualus
dilemma
forthcom
final
systemat
evalu
impact
usg
polici
regul
guidanc
institut
cost
structur
scientif
discoveri
current
usg
polici
appear
diminish
role
ibc
oversight
durc
wherea
believ
local
ibc
assum
yet
even
respons
detail
judgment
current
usg
dur
polici
provid
recommend
futur
oversight
dur
perspect
senior
administr
laboratori
scientist
charg
respons
conduct
lifesci
research
era
increas
regulatori
requir
decreas
feder
support
scope
usg
polici
limit
life
scienc
research
involv
tier
bsat
reconstruct
influenza
viru
avian
influenza
viru
bsat
seven
categori
experi
tabl
research
bsat
repres
small
fraction
life
scienc
research
current
usg
polici
provid
oversight
dur
life
scienc
train
educ
involv
scientist
call
nsabb
report
instead
provid
addit
layer
scrutini
small
segment
research
laboratori
target
personnel
addit
train
educ
even
smaller
segment
research
receiv
addit
review
us
depart
health
human
servic
dhh
prior
fund
decis
base
framework
guid
us
depart
health
human
servic
dhh
fund
decis
research
propos
potenti
gener
highli
pathogen
avian
influenza
virus
transmiss
among
mammal
respiratori
droplet
dhh
framework
although
durc
polici
dhh
framework
thoroughli
scrutin
small
segment
life
scienc
research
durc
author
durc
polici
recogn
dur
exist
outsid
current
scope
state
institut
discret
consid
categori
research
durc
potenti
ref
howev
unlik
major
institut
undertak
expand
review
dur
without
public
addit
usg
polici
thorough
discuss
durc
polici
see
chapter
usg
polici
regard
durc
far
limit
addit
bsat
research
highcontain
laboratori
mani
potenti
sourc
durc
may
aris
scientist
work
lowcontain
laboratori
amateur
biologist
experi
garag
wellpublic
exampl
dur
consid
durc
came
project
categori
dual
use
research
concern
relev
section
nih
guidelin
enhanc
harm
consequ
agent
toxin
section
iiid
disrupt
immun
effect
immun
agent
toxin
without
clinic
agricultur
justif
confer
agent
toxin
resist
clinic
agricultur
use
prophylact
therapeut
intervent
agent
toxin
facilit
abil
evad
detect
methodolog
section
section
increas
stabil
transmiss
abil
dissemin
agent
toxin
section
alter
host
rang
tropism
agent
toxin
section
iiid
enhanc
suscept
host
popul
agent
toxin
section
section
gener
reconstitut
erad
extinct
agent
toxin
list
section
durc
polici
section
section
use
ectromelia
viru
develop
immunecontracept
vaccin
wild
mice
ectromelia
viru
risk
group
agent
ident
variola
viru
nucleotid
level
use
model
smallpox
infect
ectromelia
viru
modifi
recombin
dna
techniqu
express
gene
murin
zona
pellucida
part
extracellular
matrix
surround
develop
mammalian
oocyt
upon
infect
mice
recombin
viru
immun
system
mous
recogn
foreign
antigen
synthes
antibodi
antibodi
subsequ
attack
develop
oocyt
ovari
mous
result
steril
month
durat
exampl
dur
arguabl
meet
definit
durc
provid
roadmap
construct
recombin
viru
base
exist
knowledg
techniqu
could
infect
transmit
effici
human
popul
result
steril
time
research
publish
receiv
littl
attent
underscor
difficult
recogn
dur
emphas
need
comprehens
mandatori
educ
program
dur
relev
polici
call
nsabb
report
increas
durat
steril
month
lifelong
research
express
second
gene
encod
mous
genom
ectromelia
viru
unintend
consequ
express
gene
induct
profound
immunosuppress
infect
mous
result
lethal
infect
resist
mous
strain
mice
normal
protect
vaccin
immun
public
studi
stimul
intens
debat
popular
scientif
press
research
provid
potenti
second
roadmap
construct
similarli
vaccineproof
variola
viru
second
exampl
dur
ectromelia
viru
discuss
nrc
report
one
three
exampl
dur
influenza
gainoffunct
controversi
like
provid
much
need
impetu
rollout
durc
polici
focus
bsat
includ
highli
pathogen
avian
influenza
virus
narrow
focu
durc
polici
one
two
studi
influenza
gainoffunct
controversi
would
cover
polici
even
though
studi
examin
gainoffunct
mutat
influenza
hemagglutinin
h
contribut
transmiss
influenza
viru
ferret
studi
fouchier
laboratori
erasmu
medic
center
util
natur
isol
influenza
viru
genet
modifi
sitedirect
mutagenesi
h
surfac
protein
acquisit
addit
mutat
subsequ
serial
passag
ferret
studi
would
explicitli
cover
durc
polici
hand
kawaoka
colleagu
univers
madison
use
receptorbind
studi
anim
experi
identifi
four
mutat
chang
h
protein
express
viru
contain
remain
seven
gene
segment
pandem
influenza
viru
whole
pandem
influenza
viru
one
contain
gene
h
pathogen
influenza
viru
cover
durc
polici
even
though
kawaoka
viru
construct
base
influenza
viru
highli
communic
human
thought
protect
immun
h
influenza
viru
arbitrari
exclus
one
two
studi
enhanc
review
employ
similar
gainoffunct
approach
seek
answer
experiment
question
support
idea
life
scienc
research
evalu
institut
level
durc
propos
nsabb
report
also
inconsist
classif
respiratori
pathogen
regard
durc
polici
influenza
viru
includ
durc
polici
wherea
coronavirus
cov
sever
acut
respiratori
syndrom
sar
middl
eastern
rsespiratori
syndrom
mer
sar
initi
global
pandem
novemb
result
infect
death
casefat
rate
merscov
emerg
june
caus
infect
death
casefat
rate
sarscov
merscov
infect
individu
shorter
period
time
cumul
year
influenza
viru
credit
clinic
infect
death
casefat
rate
sarscov
merscov
readili
transmiss
human
popul
influenza
viru
exampl
underscor
problem
current
usg
approach
regul
durc
relianc
durc
polici
list
bsat
suggest
potenti
pathogen
less
import
inher
danger
creat
fals
sens
secur
bsat
list
may
expand
octob
usg
announc
paus
durc
gainoffunct
research
project
fund
paus
would
enhanc
pathogen
andor
transmiss
influenza
viru
merscov
sarscov
mammalian
speci
respiratori
rout
infect
paus
would
remain
effect
robust
broad
delib
process
complet
result
adopt
new
usg
gainoffunct
research
polici
ref
process
would
includ
consult
life
scienc
commun
numer
stakehold
delib
bodi
includ
nsabb
complet
octob
anniversari
initi
fund
paus
fund
paus
also
allow
futur
expans
scope
regul
research
possibl
pathogen
suggest
expans
list
thu
view
total
usg
polici
guidanc
overse
durc
arguabl
problemat
call
review
life
scienc
research
involv
durc
small
number
agent
bsat
relianc
prescript
list
pathogen
contribut
failur
review
project
similar
durc
potenti
util
dissimilar
approach
eg
fouchier
versu
kawaoka
studi
equal
import
durc
polici
fail
address
need
review
vast
major
life
scienc
research
durc
propos
nsabb
report
see
also
chapter
durc
pathogen
bsat
potenti
creat
public
health
concern
equal
bsat
local
ibc
becom
keyston
regulatori
structur
known
nih
guidelin
see
also
chapter
note
previous
earli
year
nih
guidelin
rac
review
registr
document
involv
recombin
dna
review
approv
registr
document
condit
deleg
ibc
ibc
alon
review
approv
major
registr
document
includ
involv
durc
nih
guidelin
recogn
certain
studi
influenza
viru
involv
influenza
viru
involv
increas
risk
personnel
public
therefor
requir
increas
engin
control
enhanc
ppe
addit
practic
addit
review
fouchier
kawaoka
ferret
transmiss
studi
influenza
virus
review
section
nih
guidelin
ibc
detail
discuss
influenza
controversi
see
chapter
fouchier
kawaoka
group
care
consid
potenti
safeti
secur
risk
associ
studi
studi
review
biosafeti
biosecur
mani
differ
level
includ
peerreview
studi
section
program
review
nation
institut
allergi
infecti
diseas
niaid
ibc
evalu
propos
research
prior
commenc
work
assign
biosafeti
level
commensur
guidelin
regul
reflect
riskbenefit
analys
project
carri
biocontain
laboratori
design
specif
influenza
viru
research
staf
welltrain
personnel
oper
enhanc
enhanc
exampl
kawaoka
ferret
transmiss
experi
carri
differ
lack
automat
chemic
decontamin
exit
shower
use
respiratori
protect
base
extern
hepa
filter
airsuppli
rather
power
air
purifi
respiratori
papr
system
use
enhanc
enhanc
laboratori
addit
engin
control
personnel
protect
equip
practic
robust
occup
health
program
place
institut
importantli
appropri
institut
govern
approv
inspect
obtain
prior
commenc
work
base
standard
day
gainoffunct
influenza
viru
research
requir
addit
level
review
rac
nihoba
prior
commenc
work
see
also
chapter
durat
intens
discuss
concern
two
studi
popular
scientif
press
clear
felt
ibc
review
inadequ
reason
worthwhil
examin
close
scientif
question
research
design
answer
basi
controversi
first
human
fatal
influenza
viru
occur
hong
kong
sinc
laboratoryconfirm
clinic
infect
influenza
viru
fatal
document
sustain
humantohuman
transmiss
blue
ribbon
panel
influenza
research
recommend
niaid
pressur
lead
emerg
spread
new
viral
subtyp
especi
factor
favor
transmiss
anim
human
urgent
research
prioriti
ref
niaid
fund
dr
fouchier
kawaoka
undertak
line
research
fouchier
kawaoka
group
select
gainoffunct
experiment
approach
search
genet
chang
would
permit
effici
transmiss
influenza
viru
ferret
model
human
influenza
viru
transmiss
experiment
approach
avail
answer
research
question
gainoffunct
direct
timeproven
understand
factor
govern
evolut
influenza
viru
transmiss
human
import
implic
public
health
research
fail
identifi
mutat
enhanc
transmiss
ferret
model
could
suggest
exist
genet
barrier
creat
highli
transmiss
influenza
viru
influenza
viru
infect
human
would
destin
deadend
interact
infect
hemorrhag
diseas
virus
lassa
fever
junin
virus
regard
number
influenza
viru
research
believ
influenza
virus
h
subtyp
capabl
pandem
potenti
failur
demonstr
ferret
transmiss
mutat
influenza
viru
could
support
reduct
invest
pandem
prepared
research
influenza
viru
exampl
worldwid
least
five
vaccin
licens
influenza
develop
nearli
million
dollar
billion
dollar
spent
influenza
vaccin
japan
unit
state
respect
altern
small
number
mutat
could
identifi
support
influenza
viru
transmiss
ferret
model
could
argu
influenza
viru
potenti
evolv
pandem
viru
invest
vaccin
research
interpandem
period
worthwhil
identif
mutat
could
provid
opportun
develop
antivir
vaccin
would
efficaci
predict
viru
inform
influenza
surveil
network
research
question
clearli
import
gainoffunct
manuscript
fouchier
kawaoka
laboratori
submit
public
review
nsabb
late
part
mandat
advis
usg
biosecur
issu
nsabb
recommend
chang
revis
manuscript
subsequ
publish
follow
voluntari
moratorium
new
gainoffunct
research
influenza
viru
debat
pro
con
fouchier
kawaoka
studi
continu
unab
main
issu
concern
risk
benefit
research
public
need
enhanc
evalu
public
discuss
small
percentag
durc
whether
public
dissemin
ident
genet
mutat
enhanc
transmiss
biosecur
implic
risk
benefit
research
difficult
quantifi
subject
judgment
play
larger
role
biosafeti
level
assign
experi
tie
risk
group
involv
agent
greater
perceiv
risk
agent
personnel
carri
experi
public
accident
releas
greater
assign
biosafeti
level
appropri
select
biosafeti
level
minim
potenti
risk
import
higher
biocontain
level
associ
increas
cost
durat
experi
see
section
increas
burden
regulatori
review
research
involv
influenza
virus
carri
influenza
viru
strain
current
circul
human
popul
research
influenza
viru
carri
enhanc
strain
circul
human
popul
sinc
research
highli
pathogen
influenza
viru
carri
enhanc
enhanc
indic
addit
engin
control
personnel
protect
equip
andor
practic
sinc
influenza
gainoffunct
controversi
sever
public
estim
potenti
public
health
risk
associ
studi
genet
basi
influenza
viru
transmiss
mammalian
speci
major
studi
base
risk
estim
data
public
henkel
colleagu
first
report
describ
result
nation
bsat
theft
loss
releas
report
system
year
focus
biosafeti
biocontain
laps
howev
shall
see
studi
lack
necessari
background
inform
requir
use
data
robust
risk
analys
report
document
laboratoryacquir
infect
lai
seven
four
occur
contain
laboratori
respect
studi
conclud
major
lai
acquir
unrecogn
aerosol
exposur
lai
result
either
unrecogn
andor
unreport
exposur
presum
aerosol
releas
bsat
observ
entir
consist
studi
pike
found
distinguish
accid
exposur
event
lai
hard
byer
also
report
small
number
recogn
contain
break
studi
lai
conclus
lai
occur
aerosol
exposur
import
type
respiratori
protect
use
affect
personnel
describ
henkel
report
seven
individu
infect
contain
laboratori
may
use
respiratori
protect
requir
bmbl
wherea
four
lai
laboratori
would
employ
type
papr
respiratori
protect
bmbl
mandat
respiratori
protect
research
activ
facil
wherea
need
respiratori
protect
facil
would
determin
ibc
risk
assess
without
know
respiratori
protect
individu
infect
difficult
use
data
calcul
probabl
lai
occur
result
influenza
research
enhanc
contain
laboratori
papr
univers
prescrib
method
respiratori
protect
importantli
papr
provid
almost
protect
aerosol
infect
oper
properli
similarli
henkel
public
provid
number
individu
work
report
contain
laboratori
attribut
individu
number
biosafeti
level
final
influenza
viru
experi
carri
enhanc
contain
number
addit
safeti
featur
would
minim
frequenc
exposur
probabl
lai
use
data
set
henkel
report
deriv
rang
probabl
laboratori
creat
influenza
viru
caus
lai
rang
per
laboratori
per
year
differ
two
valu
due
author
applic
variou
assumpt
calcul
includ
impact
specif
practic
reduc
likelihood
lai
other
involv
differ
estim
number
lab
involv
research
still
other
assum
differ
probabl
lai
laboratori
use
virus
versu
bacteria
similarli
probabl
commun
lai
would
lead
pandem
estim
magnitud
pandem
equal
depend
assumpt
compar
reason
calcul
benefit
research
project
equal
difficult
discuss
lack
ancillari
detail
permit
stratif
data
henkel
report
suggest
deriv
risk
analys
may
domin
subject
assumpt
therefor
reduc
valu
determin
probabl
lai
origin
enhanc
laboratori
carri
gainoffunct
research
influenza
viru
ibc
evalu
fouchier
kawaoka
studi
prior
public
henkel
report
thu
even
limit
data
may
avail
riskbenefit
analys
inform
decis
whether
addit
biosafeti
biosecur
measur
necessari
would
meaning
lack
stratifi
exposur
lai
data
could
mitig
degre
report
describ
highcontain
biosafeti
laboratori
exposur
data
describ
detail
biocontain
context
eg
detail
descript
engin
control
personnel
protect
equip
practic
individu
work
inadvert
expos
agent
low
frequenc
becam
infect
order
continu
improv
best
practic
biocontain
biosecur
especi
import
accident
exposur
data
lack
thereof
new
stateoftheart
nation
biodefens
analysi
countermeasur
center
integr
research
facil
frederick
md
similar
facil
countri
final
along
better
data
need
agreement
scientif
commun
appropri
assumpt
use
calcul
riskbenefit
analys
durc
togeth
enabl
ibc
evalu
better
dur
project
review
current
life
scienc
research
involv
pathogen
recombin
dna
overseen
seri
biosecur
law
execut
order
administr
order
guidanc
document
nih
guidelin
dhh
framework
durc
polici
inform
actual
manner
review
process
life
scienc
research
nih
guidelin
deleg
review
approv
registr
document
condit
ibc
nih
guidelin
requir
certain
experi
potenti
involv
durc
tabl
requir
addit
level
review
exampl
deliber
transfer
drug
resist
trait
certain
microorgan
could
requir
ibc
review
rac
review
nih
director
approv
prior
initi
studi
nih
guidelin
section
iiia
also
clone
toxin
molecul
ld
less
ngkg
requir
ibc
nihoffic
biotechnolog
activ
nihoba
approv
nih
guidelin
section
iiib
nih
guidelin
also
recogn
certain
influenza
viru
studi
involv
gene
human
influenza
virus
requir
special
consider
enhanc
biocontain
addit
review
thu
mention
previous
fouchier
kawaoka
gainoffunct
studi
need
review
level
ibc
hierarch
review
approach
recombin
synthet
dna
experi
work
well
almost
year
current
durc
polici
call
evalu
dur
involv
bsat
level
institut
review
entiti
ire
often
ibc
detail
discuss
mechan
durc
review
see
also
chapter
ire
use
riskbenefit
assess
analysi
determin
whether
propos
research
durc
research
determin
durc
pi
work
conjunct
ibc
would
draft
risk
mitig
plan
guid
conduct
commun
durc
risk
mitig
plan
would
need
approv
usg
fund
agenc
approach
rais
least
three
question
first
would
use
agenc
fund
project
review
risk
mitig
plan
conflict
interest
second
individu
group
individu
would
carri
review
exampl
would
program
offic
oper
anoth
capac
review
risk
mitig
plan
would
someon
train
riskbenefit
analysi
third
would
independ
fund
agenc
ensur
consist
review
mitig
plan
ident
durc
addit
durc
polici
fund
propos
influenza
gainoffunct
studi
must
also
respons
dhh
framework
framework
influenza
viru
gainoffunct
research
propos
would
review
scientif
merit
dualus
issu
fund
agenc
propos
fundabl
rang
pass
sevenpoint
dhh
criteria
would
forward
dhh
rigor
review
base
scientif
public
health
benefit
biosafeti
biosecur
risk
risk
mitig
plan
research
project
pass
dhh
review
process
fund
agenc
approv
send
pi
notic
award
dhh
framework
also
rais
numer
question
three
list
would
fund
agenc
requir
ibc
review
registr
document
includ
riskbenefit
analysi
risk
mitig
plan
accompani
fund
solicit
would
make
sens
otherwis
dhh
review
committe
would
gener
de
novo
riskbenefit
analysi
risk
manag
plan
project
review
although
perhap
advantag
dhh
review
committe
approach
would
increas
ibc
workload
ibc
review
registr
document
award
fund
research
propos
fund
dhh
review
committe
gener
riskbenefit
analysi
would
ibc
abl
modifi
dhhsapprov
risk
mitig
plan
would
dhh
riskbenefit
assess
replac
aspect
ibc
review
final
would
dhh
risk
mitig
plan
replac
need
risk
mitig
plan
mandat
durc
polici
sinc
plan
like
would
end
place
fund
agenc
clear
work
practic
pi
ibc
addit
respons
report
requir
polici
guidelin
take
effect
like
make
pi
less
competit
research
abroad
encumb
regulatori
burden
nrc
report
nsabb
report
describ
seven
similar
categori
durc
requir
enhanc
oversight
nsabb
report
propos
evalu
life
scienc
dur
ire
possibl
ibc
expand
expertis
emphas
role
local
oversight
manag
durc
durc
would
identifi
riskbenefit
analysi
use
suit
tool
describ
nsabb
identifi
durc
would
manag
risk
mitig
plan
develop
ibc
pi
addit
level
review
describ
nrc
report
propos
review
dur
involv
bsat
level
ibc
durc
accept
risk
manag
plan
would
develop
pi
ibc
howev
author
nrc
report
recogn
certain
durc
would
greater
degre
inher
risk
would
requir
addit
level
review
base
success
nih
guidelin
facilit
research
protect
public
safeti
nrc
report
propos
similar
hierarch
review
process
evalu
durc
vast
major
dur
involv
bsat
would
handl
level
ibc
experi
seven
categori
defin
durc
polici
list
tabl
refer
expand
rac
possibl
approv
denial
permiss
proceed
propos
experi
ref
approach
ad
benefit
durc
categori
except
current
requir
nih
guidelin
review
ibc
tabl
certain
experi
categori
review
rac
nih
oba
importantli
unlik
durc
polici
nih
guidelin
requir
ibc
review
experi
involv
durc
categori
experi
involv
bsat
nih
guidelin
would
need
updat
criteria
determin
durc
would
review
sole
ibc
durc
would
requir
secondari
review
expand
central
region
rac
criteria
could
develop
nsabb
consult
scientif
commun
use
expand
rac
review
select
durc
would
number
advantag
current
approach
propos
durc
polici
one
nation
entiti
would
review
registr
document
ensur
consist
review
rac
alreadi
review
certain
categori
experi
involv
transfer
drug
resist
trait
certain
microorgan
alreadi
institut
experi
review
durc
would
minim
potenti
conflict
interest
would
improv
effect
ibc
improv
qualiti
review
durc
scenario
dhh
review
committe
would
review
scientif
public
health
benefit
pertain
research
portfolio
biosafeti
biosecur
risk
gener
risk
mitig
plan
would
left
ibc
expand
rac
prior
ibc
major
role
evalu
influenza
sarscov
merscov
gainoffunct
research
propos
biosafeti
biosecur
base
sole
nih
guidelin
reaction
influenza
controversi
inadvert
reduct
ibc
role
manag
class
experi
addit
oversight
review
process
potenti
expans
list
addit
pathogen
class
durc
fund
paus
current
reaction
gainoffunct
durc
quantit
unknow
level
risk
impos
addit
layer
oversight
andor
layer
biosafeti
biosecur
may
justifi
small
number
durc
view
vast
major
although
harder
document
emphasi
educ
profici
train
involv
lifesci
research
special
attent
individu
involv
durc
may
greater
impact
lower
risk
without
impact
scienc
see
section
increas
burden
regulatori
review
summari
argu
local
ibc
provid
increas
resourc
capabl
compet
review
registr
document
durc
manag
vast
major
forward
select
expand
rac
secondari
review
sinc
ibc
assum
role
primari
review
recombin
dna
research
dramat
increas
respons
overse
biolog
research
engag
biosecur
well
biosafeti
see
also
chapter
increas
respons
base
partli
recent
usg
polici
expand
review
role
durc
bsat
view
ibc
review
durc
expand
even
mandat
durc
polici
includ
life
scienc
research
although
would
increas
workload
ibc
would
result
comprehens
pictur
durc
life
scienc
research
especi
research
carri
laboratori
low
biosafeti
contain
biosecur
exampl
type
research
lead
durc
immunecontracept
recombin
vaccin
proof
recombin
describ
ibc
expand
review
would
also
elimin
gap
current
durc
polici
regul
research
pathogen
pandem
potenti
pathogen
current
list
dur
dilemma
least
year
old
although
adequ
address
mani
way
old
debat
ibc
also
wellposit
carri
addit
activ
warrant
chang
landscap
scienc
instanc
ibc
ideal
posit
foster
outreach
local
commun
number
import
topic
engag
public
see
also
chapter
influenza
gainoffunct
controversi
rais
concern
certain
durc
experi
riski
carri
due
low
probabl
highli
consequenti
event
lai
lead
influenza
viru
pandem
ibc
well
suit
explain
local
commun
review
process
includ
riskbenefit
assess
compon
evalu
durc
seri
usa
today
articl
suggest
nation
biocontain
laboratori
oper
safe
secur
manner
come
time
trust
scientif
establish
public
alreadi
strain
due
inadvert
shipment
live
bacillu
anthraci
live
influenza
viru
cdc
laboratori
shipment
bacillu
anthraci
armi
dugaway
prove
ground
utah
period
least
laboratori
state
washington
dc
guam
us
virgin
island
puerto
rico
nine
countri
releas
burkholderia
pseudomallei
highcontain
laboratori
tulan
nation
primat
research
center
import
note
major
mishap
occur
usg
laboratori
academ
institut
receiv
vast
major
usg
life
scienc
fund
ibc
well
suit
reassur
local
commun
safeti
secur
life
scienc
enterpris
well
import
homeland
secur
futur
gain
human
medicin
agricultur
recent
innov
open
excit
area
research
see
also
chapter
last
year
new
technolog
call
crispr
cluster
regularli
interspac
short
palindrom
repeat
evolv
tremend
pace
research
laboratori
around
world
technolog
permit
modif
dna
human
anim
plant
transcript
regul
alter
gene
ad
subtract
importantli
compar
previou
techniqu
modifi
dna
new
approach
much
faster
easier
promis
chang
manner
certain
diseas
treat
alreadi
least
one
report
chines
research
modifi
human
embryo
addit
synthet
biolog
offer
possibl
modifi
microorgan
addit
function
genet
circuit
metabol
pathway
practic
purpos
product
pharmaceut
biofuel
break
pollut
longer
term
creat
new
lifeform
final
agricultur
continu
increas
world
popul
chang
environment
condit
decreas
water
suppli
drive
plant
biotechnolog
revolut
gener
new
solut
food
secur
see
chapter
cropspecif
ibc
issu
new
area
research
requir
certain
level
oversight
ibc
best
posit
provid
although
respons
ibc
continu
expand
institut
illprepar
futur
compar
institut
anim
care
use
committe
institut
review
board
ibc
receiv
fraction
resourc
equal
greater
regulatori
burden
respons
broader
swath
scienc
usg
need
determin
mechan
directli
fund
ibc
without
leav
task
institut
see
section
regulatori
complianc
research
institut
unfund
mandat
propos
life
scienc
research
review
dualus
small
percentag
studi
durc
meet
particular
criterion
would
requir
addit
level
review
expand
rac
system
work
effect
pi
prepar
ibc
registr
document
selfidentifi
dur
may
consid
durc
part
ibc
need
separ
durc
project
evalu
complet
level
ibc
need
secondari
review
expand
rac
process
must
consist
among
ibc
ideal
project
similar
durc
would
manag
similar
risk
manag
plan
even
differ
ibc
also
would
advantag
local
ibc
staf
requir
subject
matter
expert
registr
document
receiv
thorough
evalu
could
difficult
smaller
institut
would
import
expand
avail
commerci
virtual
ibc
andor
nation
regist
train
ad
hoc
ibc
member
equal
import
pi
member
ibc
must
receiv
educ
train
dur
especi
riskbenefit
analys
much
written
need
improv
educ
train
life
scientist
nrc
report
nsabb
report
highlight
import
educ
life
scienc
commun
dur
issu
nsabb
publish
report
entitl
strateg
plan
outreach
educ
dualus
research
issu
report
describ
comprehens
educ
outreach
strategi
target
multipl
target
audienc
eg
congress
gener
public
scientist
laboratori
staff
studentstraine
research
administr
institut
leadership
multipl
venu
eg
profession
associ
scientif
societi
scientif
journal
opinion
leader
popular
press
offic
biotechnolog
activ
offic
scientif
polici
nih
sponsor
comprehens
websit
provid
educ
materi
dur
recent
durc
polici
direct
institut
must
provid
educ
train
individu
conduct
life
scienc
research
bsat
addit
educ
materi
member
nsabb
engag
target
audienc
issu
dur
offic
biotechnolog
activ
present
nih
guidelin
american
biolog
safeti
associ
annual
meet
venu
spite
educ
effort
impact
life
scienc
research
appear
modest
low
level
interest
knowledg
dualus
dilemma
shown
senior
scientist
institut
offici
major
ibc
member
pi
laboratori
staff
receiv
train
dur
importantli
littl
feder
fund
avail
direct
cost
basi
educ
dualus
issu
clear
situat
chang
usg
polici
requir
educ
train
dur
issu
individu
involv
life
scienc
research
institut
level
mention
littl
data
address
burden
ibc
complianc
andor
review
research
although
small
literatur
gener
question
regulatori
burden
faculti
workload
paper
skorton
et
al
discuss
tension
arisen
two
mission
academ
research
name
promot
support
vigor
research
agenda
regul
program
activ
compris
focus
larg
human
anim
subject
protect
articl
present
call
action
consolid
regulatori
activ
streamlin
duplic
unnecessari
report
reduc
cost
similar
discuss
literatur
avail
would
argu
progress
made
rein
regulatori
burden
year
follow
plea
fact
problem
appear
get
wors
nation
academi
scienc
report
found
pi
spent
almost
half
time
assign
feder
fund
project
meet
requir
impos
project
mani
separ
administr
activ
preand
postaward
identifi
nationwid
survey
life
scienc
research
conduct
center
biodefens
law
public
polici
examin
degre
anxieti
inadvert
violat
bsat
regul
survey
test
hypothesi
bsat
regul
despit
uncertainti
regard
current
structur
dissemin
guidelin
regul
survey
show
scientist
overwhelmingli
favor
continu
regul
particular
interest
observ
mani
research
concern
commit
violat
person
injuri
data
present
disturb
pictur
kind
pressur
person
regulatori
mani
user
ibc
may
experienc
although
date
survey
year
feder
bsat
program
leav
room
possibl
ibc
regul
sinc
clarifi
attitud
adjust
dia
et
al
examin
effect
usa
patriot
act
bioterror
prepared
act
bsat
research
us
salient
programmat
observ
measur
attrit
field
studi
topic
bacillu
anthraci
compar
control
topic
klebsiella
pneumonia
result
indic
averag
number
paper
deal
bacillu
anthraci
number
declin
three
contrast
similar
account
paper
focus
klebsiella
pneumonia
found
smaller
decreas
research
paper
per
million
dollar
us
fund
thu
bsat
research
activ
drop
gener
pathogen
research
drop
author
recogn
number
problem
analysi
number
may
soft
data
clearli
indic
decreas
certain
bsat
research
estim
number
bsat
research
paper
publish
unit
state
number
public
discuss
efficaci
current
bsat
program
relat
abil
ibc
contribut
biosecur
biosafeti
avenu
dualus
review
inventori
personnel
reliabl
sop
evalu
etc
potenti
contribut
ibc
kind
biosecur
issu
discuss
chapter
volum
see
chapter
novel
approach
reliev
burden
ibcrel
respons
bosselman
et
al
address
problem
staff
turnov
train
requir
anxieti
duplic
record
risk
assess
etc
analyz
specif
issu
caus
burden
delay
found
major
obstacl
ibc
protocol
manag
coordin
correspond
investig
review
manag
train
inform
recordkeep
laboratori
inspect
solut
creat
collabor
platform
organ
display
data
document
task
coordin
structur
process
requir
progress
could
track
simultan
mors
describ
evolut
implement
pathogenrel
regul
outlin
discuss
within
research
commun
effect
product
intern
collabor
cost
mors
point
mani
propos
neg
impact
se
regul
base
anecdot
evid
exampl
number
microbi
collect
destroy
investig
bsat
regul
came
effect
bsat
program
tri
prevent
loss
move
cultur
collect
regist
laboratori
mani
research
complain
use
research
fund
upgrad
laboratori
appropri
secur
standard
gaudioso
salerno
bemoan
loss
person
institut
talent
appli
bsat
research
relat
flight
field
directli
burdensom
natur
registr
complianc
one
highprofil
research
announc
would
chang
research
focu
rather
submit
regul
bsat
requir
grown
restrict
demand
ensu
year
sutton
argu
research
sole
target
current
biosafeti
biosecur
regul
inde
sutton
develop
argument
alleg
perpetr
anthrax
attack
would
detect
current
bsat
program
add
may
time
rethink
regulatori
framework
nation
biodefens
research
focus
fulli
implement
background
investig
requir
better
perimet
secur
place
less
emphasi
fill
form
file
report
count
unit
selfrepl
organ
recent
implement
personnel
suitabl
assess
program
feder
bsat
program
program
intend
determin
whether
person
intend
work
tier
bsat
actual
warrant
access
attend
bureaucrat
respons
increas
recent
report
review
trend
ibc
practic
evalu
respons
survey
ibc
regist
cdc
data
mix
incid
train
incid
report
remain
problemat
interact
regulatori
committe
institut
anim
care
use
committe
iacuc
institut
review
board
irb
improv
manag
staf
complianc
improv
year
cover
survey
jenkin
point
hackney
studi
use
analyz
gener
trend
develop
ibc
lack
quantit
data
increas
registr
polici
burden
ibc
time
well
number
protocol
review
administr
resourc
financi
support
defens
biolog
threat
natur
intent
maintain
posit
high
prioriti
basic
research
public
health
clinic
enterpris
secur
implic
spread
infecti
diseas
gone
unnot
nation
global
level
furthermor
impact
anthrax
attack
felt
throughout
global
commun
event
significantli
transform
landscap
basic
scienc
enterpris
particularli
field
infecti
diseas
discuss
burden
associ
bsat
infecti
diseas
research
leav
number
question
unansw
maintain
safe
secur
research
facil
conduct
research
effici
factor
impact
research
polici
research
qualiti
product
find
healthi
balanc
facilit
research
protect
audit
legal
concern
go
forward
ibc
play
increasingli
central
role
increasingli
complex
regulatori
environ
associ
life
scienc
research
reliabl
quantif
burden
ibc
requir
research
enterpris
remain
unavail
order
exploit
expertis
contribut
offer
wellinform
ibc
burden
place
committe
warrant
systemat
review
document
previou
chapter
scientif
commun
collabor
activ
feder
govern
recogn
minim
risk
durc
equal
obviou
howev
measur
individu
collect
requir
research
institut
commit
substanti
resourc
institut
assum
full
financi
respons
issu
rais
develop
whether
institut
assum
respons
want
conduct
durc
instead
issu
whether
institut
resourc
adequ
ensur
safe
secur
conduct
durc
especi
time
mani
research
institut
face
increas
financi
stress
relat
conduct
research
stress
function
sever
trend
appli
gener
feder
fund
clear
implic
durc
decreas
level
fund
biomed
research
past
decad
actual
dollar
percentag
feder
budget
ii
inexor
increas
feder
regul
sinc
year
current
cap
administr
cost
feder
award
establish
exact
cumul
financi
burden
regulatori
complianc
follow
section
consid
issu
detail
feder
fund
biotechnolog
research
long
critic
scientif
advanc
turn
contribut
improv
public
health
grow
economi
fund
also
occas
growth
bioscienc
nih
fund
support
research
univers
research
institut
reflect
critic
role
nih
fund
biomed
scienc
commun
longstand
critic
support
bioscienc
enterpris
feder
research
fund
proport
feder
budget
declin
steadili
past
halfcenturi
account
less
budget
see
figur
million
request
declin
moreov
trend
project
continu
aftermath
sequest
ongo
polit
squabbl
fund
domest
program
paradox
declin
fund
come
time
number
applic
fund
increas
examin
applic
recent
data
success
rate
avail
show
allag
applic
increas
consequ
increas
applic
decreas
pool
fund
success
rate
nih
award
also
declin
period
increas
institut
research
cost
reflect
data
collect
nation
scienc
foundat
annual
higher
educ
research
develop
herd
survey
show
institut
fund
directli
support
research
total
billion
combin
institut
support
associ
indirect
ie
facil
administr
expens
institut
fund
account
research
develop
expenditur
compar
r
expenditur
henc
institut
r
fund
second
provid
feder
sourc
moreov
escal
institut
complianc
requir
associ
durc
suggest
financi
burden
institut
provid
intern
research
fund
continu
increas
trend
threaten
financi
abil
strongest
research
institut
support
research
enterpris
note
research
institut
face
rise
cost
associ
longterm
trend
place
increas
pressur
direct
indirect
researchrel
expens
direct
indirect
cost
research
repres
real
institut
expenditur
direct
cost
cours
element
readili
identifi
repres
bulk
award
research
project
suppli
research
equip
investig
salari
etc
indirect
cost
clearli
link
given
project
includ
expens
facil
infrastructur
oper
activ
eg
electr
heat
ventil
mainten
dispos
hazard
wast
well
cost
associ
administr
award
eg
complianc
regul
cost
control
financi
report
inform
secur
case
research
involv
bsat
addit
indirect
cost
involv
secur
system
personnel
mainten
special
engin
control
hvac
system
administr
panel
evalu
suitabl
researchrel
personnel
personnel
assur
program
requir
respons
offici
overse
program
administr
see
also
chapter
impetu
feder
govern
set
facil
administr
f
rate
cours
support
indirect
cost
associ
conduct
feder
fund
research
henc
f
rate
negoti
institut
receiv
feder
fund
typic
via
audit
undertaken
institut
expens
everi
year
institut
f
rate
subject
chang
either
time
maximum
amount
administr
expens
institut
claim
cap
direct
cost
feder
award
rate
set
signific
year
feder
oversight
research
year
formula
set
f
rate
also
year
common
rule
adopt
provid
human
subject
protect
across
feder
agenc
cap
administr
cost
rate
unchang
sinc
said
regulatori
landscap
contribut
cost
recent
council
govern
relat
cogr
compil
list
regul
implement
amend
well
interpret
implement
impact
busi
practic
document
list
regulationsamend
interpretationsimplement
nine
regulatori
chang
propos
time
document
publish
partial
list
regulatori
requir
follow
investig
familiar
mani
impact
manag
feder
fund
award
face
ongo
need
compli
regulatori
andor
financi
report
requir
research
institut
develop
multipl
structur
manag
recurr
function
reflect
degre
complianc
committe
mani
involv
faculti
represent
includ
irb
iacuc
ibc
ire
conflict
interest
coi
committe
etc
committe
larg
depend
willing
research
faculti
volunt
time
support
committe
function
infrastructur
behind
committe
support
voluntari
basi
inde
infrastructur
requir
expert
personnel
inform
system
offic
space
institut
resourc
multipl
oper
vari
organiz
structur
support
difficult
obtain
exact
account
institut
cost
exact
compliancerel
oper
said
sever
recent
studi
provid
estim
cost
associ
array
researchrel
regulatori
requir
associ
feder
fund
previous
referenc
herd
studi
estim
indirect
cost
incur
research
institut
exceed
feder
f
support
billion
dollar
anoth
survey
undertaken
associ
american
medic
colleg
aamc
examin
indirect
cost
medic
school
research
program
receiv
feder
fund
rang
moder
million
high
million
level
studi
show
institut
expenditur
unreimburs
indirect
cost
extern
award
averag
per
dollar
direct
cost
note
previous
intern
expenditur
also
incur
eg
startup
packag
addit
salari
support
research
effort
bridg
fund
combin
institut
cost
amount
per
dollar
direct
cost
cours
cost
complianc
measur
dollar
visit
research
institut
cost
visit
investig
well
often
form
reduc
research
product
data
regard
reduc
product
collect
feder
demonstr
partnership
fdp
collabor
among
feder
agenc
feder
fund
institut
partner
sponsor
nation
academi
fdp
survey
complet
princip
investig
activ
feder
grant
respons
rate
respond
identifi
mani
administr
function
consum
effort
see
tabl
greatli
reduc
estim
proport
fund
effort
actual
spent
activ
research
biomed
research
institut
increas
financi
pressur
face
declin
level
nih
fund
accumul
administr
cost
associ
everincreas
regulatori
financi
report
requir
latter
trend
affect
research
institut
might
argu
particularli
affect
engag
durc
safeti
secur
requir
form
research
particularli
steep
fact
requir
suffici
demand
research
institut
move
away
durc
research
cost
continu
investig
rel
cost
form
biomed
research
henc
rel
biomed
research
gener
durc
specif
may
approach
tip
point
declin
qualiti
research
infrastructur
complianc
oversight
gradual
degrad
laboratori
facil
ultim
lost
conduct
research
strain
research
institut
particular
note
light
current
bioterror
threat
underscor
import
scientif
breakthrough
mitig
effect
threat
inde
congress
recogn
threat
import
scientif
breakthrough
part
nation
strategi
respond
bioterror
unfortun
effect
scientif
arm
war
terror
undercut
converg
stress
discuss
shift
increas
cost
research
onto
research
institut
although
cost
shift
may
inadvert
magnitud
substanti
longterm
effect
prejudici
health
us
scientif
enterpris
time
potenti
truli
signific
breakthrough
histor
high
level
sever
recent
report
target
unfund
mandat
associ
regulatori
burden
major
contributor
tip
point
exampl
one
report
address
broad
challeng
face
research
univers
recommend
action
sever
aim
mitig
regulatori
burden
describ
feder
award
fulli
fund
direct
indirect
cost
research
recommend
ii
feder
govern
reduc
costli
regul
substanti
improv
research
environ
recommend
similar
theme
echo
anoth
report
advanc
specif
solut
year
cost
maintain
balanc
grown
visit
disproportion
institut
scientif
work
occur
advanc
continu
rebalanc
histor
success
universityfeder
partnership
need
believ
chang
propos
chapter
could
rebal
partnership
allow
research
institut
remain
viabl
enterpris
accommod
scientif
discoveri
benefit
human
health
precaut
necessari
ensur
safeti
secur
broader
societi
